Quick Takeaways
- Sarah A. Teichmann has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $519,799.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Sarah A. Teichmann
- Location
- Pleasanton, CA
- Summary
- The estimated net worth of Sarah A. Teichmann is at least $519,799 dollars as of 27 Feb 2026. Sarah A. Teichmann is the Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $519.8K.
- Signature
- /s/ Randy Wu, as Attorney-in-Fact for Sarah A. Teichmann
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Sarah A. Teichmann and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: 10x Genomics, Inc. ($519,799).
- Past-year value change for that position: -$147,108.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Sarah A. Teichmann
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | Director | $519,799 | -$147,108 | -22% | 25 Feb 2026 |
Insider Transactions Reported by Sarah A. Teichmann:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.